New Syrris Asia catalogue highlights the benefits of flow chemistry
23 November 2011 | By kdm communications limited
Syrris is pleased to announce the release of its new Asia flow chemistry reactors catalogue...
List view / Grid view
News
A drug for Type 1 diabetes meets primary and secondary goals of Phase III clinical trials
23 November 2011 | By Weizmann UK
The clinical trial was random, regulated, double-blinded and broad-based...
Pfizer to acquire Excaliard Pharmaceuticals
22 November 2011 | By Pfizer
Lead program includes novel investigational compound for prevention/treatment of skin scarring...
NDA for aripiprazole depot formulation for maintenance treatment of adult patients with schizophrenia accepted
22 November 2011 | By H. Lundbeck A/S (Lundbeck)
H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced today that the US Food and Drug Administration (FDA) has determined that a new drug application (NDA) for Otsuka's investigational once-monthly aripiprazole depot formulation for the indication of maintenance treatment of schizophrenia in adults is sufficiently complete to permit…
Sunrise™ in Mongolia
22 November 2011 | By kdm communications limited
Donation of a Tecan Sunrise™ microplate reader to Mongolian medical researchers, assisting their studies of vitamin D levels in the general population...
Merck resolves previously disclosed seven-year investigation
22 November 2011 | By Merck
Merck has reached a resolution with federal and state authorities regarding a previously disclosed investigation concerning Vioxx...
Pfizer and MIT break ground on new research units in Kendall Square
21 November 2011 | By Pfizer
10-year lease marks a strategic partnership between the academic research community and industry to boost innovation...
Gilead Sciences to acquire Pharmasset, Inc. for $11 billion
21 November 2011 | By Gilead Sciences
Gilead Sciences, Inc., will acquire Pharmasset, Inc., for $137 per share in cash...
Abbott introduces the first FDA-approved supplemental blood test for Chagas disease
21 November 2011 | By Abbott
Abbott received approval from the U.S. FDA for a new Chagas in vitro diagnostic test...
Pfizer announces EMA acceptance of regulatory submission for Tofacitinib for the treatment of Rheumatoid Arthritis
21 November 2011 | By Pfizer
Pfizer Inc. announced that its Market Authorisation Application for tofacitinib...
FDA Commissioner announces final decision on Avastin for metastatic breast cancer
18 November 2011 | By Roche
FDA Commissioner revokes approval of Avastin for treatment of mBC in the US...
CAPRELSA™ (vandetanib) receives positive CHMP opinion in the European Union for treating advanced medullary thyroid cancer
18 November 2011 | By AstraZeneca
CAPRELSA receives a positive opinion...
GlaxoSmithKline welcomes innovative knowledge-sharing collaboration to break deadlock in antibiotic discovery and development
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
GSK welcomes GAVI Alliance decision to introduce vaccines against cervical cancer and rubella in the world’s poorest countries
17 November 2011 | By GlaxoSmithKline
GSK welcomed the decision of the GAVI...
Lilly provides additional funding to Infectious Disease Research Institute to identify new Tuberculosis therapies
17 November 2011 | By Eli Lilly and Company
Eli Lilly and Company is providing more than $4 million in additional funding...
